Interpharm Holdings (IPAH) Financial Statements

2 Followers

Interpharm Holdings Financial Overview

Interpharm Holdings's market cap is currently $667.00. The company's EPS TTM is $; its P/E ratio is -0.02; Interpharm Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 07	Jun 06	Jun 05	Jun 04	Jun 03
Income Statement
Total Revenue
Gross Profit	$ 21.67M	$ 17.43M	$ 9.07M	$ 9.79M	$ 2.74M
Operating Income	$ -10.74M	$ -4.77M	$ -95.00K	$ 5.06M	$ 1.24M
EBITDA	$ -8.18M	$ -3.23M	$ 1.15M	$ 5.95M	$ 1.56M
Net Income	$ -14.06M	$ -3.79M	$ -149.00K	$ 3.12M	$ 723.64K
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 74.37M	$ 62.87M	$ 46.39M	$ 35.17M	$ 20.34M
Total Debt	$ 26.55M	$ 15.64M	$ 17.03M	$ 7.83M	$ 2.53M
Net Debt	$ 26.47M	$ 14.20M	$ 16.49M	$ 4.90M	$ 141.89K
Total Liabilities	$ 62.95M	$ 40.04M	$ 23.28M	$ 12.38M	$ 7.87M
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow	$ -22.11M	$ -6.03M	$ -10.46M	$ -2.30M	$ -830.97K
Operating Cash Flow	$ -14.11M	$ 801.00K	$ -2.35M	$ 2.13M	$ 200.43K
Investing Cash Flow
Financing Cash Flow

Currency in USD

Interpharm Holdings Earnings and Revenue History

Income Statement >

Interpharm Holdings Debt to Assets

Balance Sheet >

Interpharm Holdings Cash Flow

Cash Flow >

Interpharm Holdings Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >